Astia Angels
VC Fund
San Francisco, United States
Astia Angels is a global network of both female and male angel investors that invest in high-growth companies. The angel investor network is actively engaged in the Astia community and screening process (Astia Expert Sift TM) and founded by experienced angel investors. All members are highly involved throughout the investment process and makeindependent investment decisions.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 9%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Astia Angels invests in
Stages Astia Angels invests in
Countries Astia Angels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 20 contacts → | |||
Round size
- Seed
- $425k–$5M
- Angel
- $200k–$1.8M
- Series A
- $2.3M–$33M
Investment Focus
Industry
- Health Care 19 (29%)
- Biotechnology 10 (15%)
- Medical Device 10 (15%)
- Manufacturing 6 (9%)
- Artificial Intelligence 6 (9%)
Stage
- Seed 20 (30%)
- Series A 15 (23%)
- Angel 7 (11%)
- Series B 6 (9%)
- Funding Round 5 (8%)
Country
- United States 41 (62%)
- United Kingdom 3 (5%)
- Canada 1 (2%)
- Israel 1 (2%)
- Ireland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anula Jayasuriya
Member of the Board of Trustees
|
Member of the Board of Trustees | Total investments: 1 | Find email | |
Adam Quinton
Founding Astia Angel
|
Founding Astia Angel | Total investments: 6 | Find email | |
|
Anne LaFolette
Astia Angel
|
Astia Angel | Total investments: 0 | Find email | |
Barbara Clarke
Founding Member
|
Founding Member | Total investments: 25 | Find email | |
Corinne Nevinny
Astia Angel Member
|
Astia Angel Member | Total investments: 1 | Find email | |
| See all 20 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ocon Healthcare
|
OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility. | $10M / Series A / Jun 24, 2024 | |
Ellevest
|
Ellevest provides an engaging investing experience to help women meet their financial goals in life.Ellevest offers a modern, engaging user experience. The same care, thoughtfulness, and attention to detail that is reflected in its beautiful, easy-to-use interface are applied to the construction of its portfolios, its selection of investments,and the development of the algorithms that drive its forecasts and recommendations. | $53M / Series B / Apr 06, 2022 | |
|
Ellevest
|
Ellevest provides an engaging investing experience to help women meet their financial goals in life.Ellevest offers a modern, engaging user experience. The same care, thoughtfulness, and attention to detail that is reflected in its beautiful, easy-to-use interface are applied to the construction of its portfolios, its selection of investments,and the development of the algorithms that drive its forecasts and recommendations. | $53M / Series B / Apr 06, 2022 | |
ORNA
|
ORNA is an end-to-end incident response automation platform for small and midsize businesses that helps streamline or automate detection, response, and even prevention of cyberattacks on the organization's assets, all in a single tool with live 24/7 specialist support.The platform monitors cloud, on-premises, and hybrid assets (such asservers, network devices, workstations, IoT devices, and more) the organization is looking to protect around the clock, but also brings together overarching cyber incident response across all business functions, such as legal, HR, communications, and others; as well as automates evidence collection, communications, vulnerability management, and more.Main features include:Threat detection: 24/7 automated AI-led detection, triage, and containment of external and internal threats in an estimated 1/80,000s of a second.Incident response: if a threat becomes significant, ORNA invokes automated, attack scenario-specific Playbooks that cover all necessary actions across your business. ORNA guides your team across identification, containment, recovery, evidence preservation, reporting, out-of-band communications activities, and more with a single goal - reduce financial and reputation damage to your business.Threat prevention: ORNA contains NIST-based compliance, asset risk and vulnerability management, team management, IR/DR/BCP process creation, team training, and other functions designed to help you prevent threats from actualizing in the first place. | $842.5K / Seed / Jan 01, 2022 | |
Cooler Heads
|
Cooler Heads develops cold caps designed for chemotherapy patients. | $1.5M / Seed / Dec 08, 2021 | |
Osteoboost
|
Bone Health Technologies specializes in developing medical devices designed for low bone mass. Its solution is a gentle mechanical stimulation that mimics weight-bearing exercise, providing an effective non-drug intervention. It offers the OsteoBoost device that relies on safe, natural, and effective whole-body vibration technology usingvibrational energy to turn stem cells into the bone using the same mechanisms as physical exercise. The company was founded in 2018 and is headquartered in San Francisco, California. | $2.5M / May 05, 2021 | |
Zenflow
|
Zenflow was founded in 2014 by a team of Stanford University Biodesign Fellows working in collaboration with top global urologists. After witnessing patients' frustration with existing treatment options, the founders made it their mission to find a better solution to this large unmet clinical need. | $24.4M / Series B / Apr 15, 2021 | |
Materna Medical
|
Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers,and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health. | $10M / Series A / Apr 09, 2021 | |
|
Osteoboost
|
Bone Health Technologies specializes in developing medical devices designed for low bone mass. Its solution is a gentle mechanical stimulation that mimics weight-bearing exercise, providing an effective non-drug intervention. It offers the OsteoBoost device that relies on safe, natural, and effective whole-body vibration technology usingvibrational energy to turn stem cells into the bone using the same mechanisms as physical exercise. The company was founded in 2018 and is headquartered in San Francisco, California. | $2.3M / Series A / Dec 18, 2020 | |
BRAINBox Solutions
|
BRAINBox provides objective evidence of injury and prediction of patient recovery. BRAINBox Solutions' multi-modality approach is led by the leaders in the industry. It includes blood biomarker panels available on a point of care instrument and standard laboratory systems. | $23M / Series A / Dec 08, 2020 | |
| See all 66 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Astia Angels invest in?
Astia Angels invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 66 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Astia Angels's check size?
Astia Angels typically joins rounds of $425k–$5M at Seed, $200k–$1.8M at Angel and $2.3M–$33M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Astia Angels participates in.
How do I contact Astia Angels?
Public channels for Astia Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Astia Angels?
The team at Astia Angels includes Anula Jayasuriya (Member of the Board of Trustees), Adam Quinton (Founding Astia Angel) and Anne LaFolette (Astia Angel), among 20 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
